Repaglinide 65862-0670
Product NDC
65862-0670- Manufacturer
- Aurobindo Pharma Limited
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 22, 2014
- Listing Expires
- December 31, 2026
- Application
- ANDA203820
Need to source Repaglinide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Repaglinide | .5 mg/1 |
Drug Class
Glinide [EPC]Glinide [EPC]Potassium Channel Antagonists [MoA]
Packaging Options(3)
100 TABLET in 1 BOTTLE (65862-670-01)
500 TABLET in 1 BOTTLE (65862-670-05)
1000 TABLET in 1 BOTTLE (65862-670-99)